(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QBIOMARKER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QBIOMARKER

ST13

US500000085838804

Class

1, 9

Filing

85838804

Registration

5176588

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

04/05/2026

Trademark type

Word

Nice classes

1, 9

Filing date

02/01/2013

Registration date

04/04/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/11/2023

Last transaction

04/05/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/27/2010

First use in commerce

08/27/2010

Drawing code

4

Owner type

16

Owner location

GERMANTOWN, MD, US

Examiner

FALK, JONATHAN ROBERT

Law office

M20

Current location

TMO LAW OFFICE 111

Holders and representatives

Holders

QIAGEN SCIENCES, LLC
SABiosciences Corp.

Representatives

Victoria Friedman Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 1Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biotechnological products for industrial and scientific purposesdiagnostic preparations except for human or veterinary medical purposesnon-medical reagentsenzymes and buffer solutions for scientific and medical research use for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplificationsequencing and analysis; Kits comprising chemicals for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids or biological or biochemical sample materialin particular comprising chemicals for reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplificationsequencing and analysis

Class 9

Scientific apparatusesinstruments and devicesas well as their parts and componentsPCR platescovers for PCR plateslaboratory tubes and tissue culture plates; computer software for use in scientific and medical research; computer software in the area of analysis of nucleic acids

Publications

History of USPTO decisions and trademark events.

52 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/04/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/11/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/11/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/11/2023

E815

TEAS SECTION 8 & 15 RECEIVED

03/13/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/04/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/25/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/24/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/04/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/03/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/03/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/04/2016

GNRT

NON-FINAL ACTION E-MAILED

10/04/2016

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/04/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/13/2016

IUAF

USE AMENDMENT FILED

09/12/2016

EISU

TEAS STATEMENT OF USE RECEIVED

09/12/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/09/2016

EX4G

SOU EXTENSION 4 GRANTED

03/08/2016

EXT4

SOU EXTENSION 4 FILED

03/03/2016

EEXT

SOU TEAS EXTENSION RECEIVED

03/03/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/24/2015

EX3G

SOU EXTENSION 3 GRANTED

06/23/2015

EXT3

SOU EXTENSION 3 FILED

06/19/2015

EEXT

SOU TEAS EXTENSION RECEIVED

06/19/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/24/2015

EX2G

SOU EXTENSION 2 GRANTED

01/23/2015

EXT2

SOU EXTENSION 2 FILED

01/21/2015

EEXT

SOU TEAS EXTENSION RECEIVED

01/21/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/23/2014

EX1G

SOU EXTENSION 1 GRANTED

09/20/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/19/2014

EXT1

SOU EXTENSION 1 FILED

09/10/2014

EEXT

SOU TEAS EXTENSION RECEIVED

09/10/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/18/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2014

PUBO

PUBLISHED FOR OPPOSITION

01/21/2014

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/01/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/14/2013

ALIE

ASSIGNED TO LIE

12/14/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/15/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2013

GNRT

NON-FINAL ACTION E-MAILED

05/20/2013

CNRT

NON-FINAL ACTION WRITTEN

05/20/2013

DOCK

ASSIGNED TO EXAMINER

05/15/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/07/2013

NWAP

NEW APPLICATION ENTERED

02/05/2013

Continuous trademark protection

Get notified about every new filing that threatens QBIOMARKER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.